UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000022813
Receipt No. R000026196
Official scientific title of the study Prospective evaluation of 20G core needle for EUS-guided histology of pancreatic tumor
Date of disclosure of the study information 2016/06/22
Last modified on 2018/12/04 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Prospective evaluation of 20G core needle for EUS-guided histology of pancreatic tumor
Title of the study (Brief title) Prospective evaluation of 20G core needle for EUS-guided histology of pancreatic tumor
Region
Japan

Condition
Condition Pancreatic neoplasm
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To assess the quality of histological specimen obtained by 20G core needle
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Quality of histology
Key secondary outcomes The accuracy rate of histology and cytology, The success rate of EUS-FNA, Feasibility of immunohistochemical analysis, the incidence of adverse events

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Pancreatic tumor in size >10mm
2) age >20
Key exclusion criteria 1) Performance status 4
2) Pregnant woman
3) Platelet count <50,000/mm3
4) PT-international normalized ratio >1.5 or
Target sample size 50

Research contact person
Name of lead principal investigator Hirotoshi Ishiwatari
Organization Shizuoka Cancer Center
Division name Division of Endoscopy
Address 1007 Shimonagakubo Nagaizumicho Suntogun Shizuoka
TEL 055-989-5222
Email ishihiro481019@gmail.com

Public contact
Name of contact person Hirotoshi Ishiwatari
Organization Shizuoka Cancer Center
Division name Division of Endoscopy
Address 1007 Shimonagakubo Nagaizumicho Suntogun Shizuoka
TEL 055-989-5222
Homepage URL
Email ishihiro481019@gmail.com

Sponsor
Institute Division of Endoscopy, Shizuoka Cancer Center
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 06 Month 22 Day

Progress
Recruitment status Main results already published
Date of protocol fixation
2016 Year 06 Month 02 Day
Anticipated trial start date
2016 Year 06 Month 20 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information none

Management information
Registered date
2016 Year 06 Month 21 Day
Last modified on
2018 Year 12 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026196